Company
Saudi Pharmaceutical Industries and Medical Appliances Corp
Headquarters: Buraydah, Saudi Arabia
Market Cap
SR3.13 Billion
SAR as of July 1, 2025
US$835.8 Million
Saudi Pharmaceutical Industries and Medical Appliances Corp Categories
Saudi Arabia Healthcare Drug Manufacturers—Specialty & GenericSaudi Arabia Healthcare Saudi Arabia Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria. The company is also involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; and wholesale and retail of medicines and related products. In addition, it develops, manufactures, and sells pharmaceutical products and medical appliances; operates and maintains healthcare facilities. Further, the company engages in the research and development of medical science. The company was founded in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.
Financials
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | SR1.69 B |
| EBITDA | SR288.1 M |
| Gross Profit TTM | SR793.8 M |
| Profit Margin | 3.55% |
| Operating Margin | 13.21% |
| Quarterly Revenue Growth | 1.90% |
Stocks & Indices
Saudi Pharmaceutical Industries and Medical Appliances Corp has the following listings and related stock indices.
Stock: Tadawul: 2070 wb_incandescent